谁有13价肺炎球菌结合疫苗失败的风险?
研究基于马萨诸塞州18岁以下儿童侵袭性肺炎球菌病的强化被动监测数据,用三种机器学习算法组成的集成模型预测13价肺炎球菌结合疫苗失败概率。7年间共识别296例侵袭性肺炎球菌病,其中107例(36%)由疫苗血清型引起,37例(34%)发生在完全接种疫苗的儿童中。疫苗失败更可能见于60月龄以上儿童、有基础合并症者及以肺炎就诊者。
要点
- 60月龄以上儿童疫苗失败预测概率0.40,观察患病率0.37,模型准确率79%。
- 有基础合并症儿童疫苗失败预测概率0.24,观察患病率0.23,模型准确率96%。
- 完成3剂基础免疫加1剂加强剂PCV13的儿童疫苗失败可能性最低,预测概率0.14,观察患病率0.14,模型准确率100%。
核心结论
- PCV13疫苗失败在年龄较大、有基础合并症的儿童以及以肺炎球菌性肺炎就诊的儿童中更常见。
- 本研究提供了预测疫苗失败模式的初步框架,可能有助于优化PCV免疫程序的决策过程。
研究设计与样本
- 研究使用马萨诸塞州18岁以下儿童侵袭性肺炎球菌病基于人群的强化被动监测数据,研究期间为2010年4月1日至2017年3月31日共7年。
- 采用由三种机器学习算法组成的集成模型预测PCV13疫苗失败概率并评估年龄、基础合并症、临床表现和疫苗接种程序等潜在相关特征。
- 疫苗失败定义为儿童按免疫实践咨询委员会推荐接种年龄推荐剂次后发生由疫苗血清型引起的侵袭性肺炎球菌病。
主要发现
- 7年研究期间共识别296例侵袭性肺炎球菌病病例,其中107例(36%)由疫苗血清型引起,主要为血清型19A(49例,17%)、7F(21例,7%)和3(18例,6%)。
- 37例(34%)发生在完全接种疫苗的儿童中,占所有侵袭性肺炎球菌病病例的13%。
- 60月龄以上儿童疫苗失败预测概率0.40,观察患病率0.37,模型预测准确率79%。
- 以肺炎就诊的儿童疫苗失败预测概率0.27,观察患病率0.31,模型准确率77%。
- 有基础合并症的儿童疫苗失败预测概率0.24,观察患病率0.23,模型准确率96%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite high vaccine coverage rates in children and efficacy of pneumococcal conjugate vaccines, invasive pneumococcal disease (IPD) episodes due to serotypes included in the vaccine following completion of the recommended course of immunisation (i.e. vaccine failure) have been reported. METHODS: We used data gathered from a population-based enhanced passive surveillance for IPD in children under 18 years of age in Massachusetts and an ensemble model composed of three machine-learning algorithms to predict probability of 13-valent pneumococcal conjugated vaccine (PCV13) failure and to evaluate potential associated features including age, underlying comorbidity, clinical presentation, and vaccine schedule. Vaccine failure was defined as diagnosis of IPD due to vaccine serotype (VST), in a child who received age recommended doses recommended by Advisory Committee of Immunization Practices. RESULTS: During the 7-year study period, between April 01, 2010 and March 31, 2017, we identified 296 IPD cases. There were 107 (36%) IPD cases caused by VST, mostly serotype 19A (49, 17%), 7F (21, 7%), and 3 (18, 6%). Thirty-seven (34%) were in children who were completely vaccinated representing 13% of all IPD cases. Vaccine failure was more likely among children older than 60 months (predicted probability 0.40, observed prevalence 0.37, model prediction accuracy 79%), children presenting with pneumonia (predicted probability 0.27, observed prevalence 0.31, model accuracy 77%), and children with underlying comorbidity (predicted probability 0.24, observed prevalence 0.23, model accuracy 96%). Vaccine failure probability for those >60 months of age and had an underlying risk factor was 45% (observed prevalence 0.33, model accuracy 82%). The likelihood of vaccine failure was lowest among children who had completed 3 primary doses plus one booster dose PCV13 (predicted probability 0.14, observed prevalence 0.14, model prediction accuracy 100%). CONCLUSION: PCV13 vaccine failure is more frequent among older children with underlying comorbidity, and among those who present with pneumococcal pneumonia. Our study provides a preliminary framework to predict the patterns of vaccine failures and may contribute to decision-making processes to optimize PCV immunization schedules.
引用
- Yildirim M, Keskinocak P, Pelton S, et al. Who is at risk of 13-valent conjugated pneumococcal vaccine failure? Vaccine. 2020. PMID: 31974018. doi:10.1016/j.vaccine.2019.12.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。